Archives
The Gantenerumab Trial
26 February 2016
This study looks at an exciting opportunity to get involved in testing new medication for people with Alzheimer’s Disease. Aims of the Study Alzheimer’s disease is a major global public health problem, and there are nearly 30 million people with the disease worldwide. Alzheimer’s disease is an irreversible, progressive neurodegenerative disease which causes a gradual […]
